Sun Pharma Allots INR 7,816 Crore NCDs via Private Placement
Sun Pharmaceutical Industries Ltd 路 Others (Uncategorized) 路 26 Oct 2026, 6:00 pm
Sun Pharma Allots INR 7,816 Crore NCDs via Private Placement Sun Pharmaceutical Industries completed the private placement allotment of rated, listed, unsecured, redeemable NCDs aggregating to INR 7,816 crore on 26th Oct'26. The issue comprises Series A NCDs worth INR 2,003 crore at an 8.05% p.a. coupon with a put option on 27th Mar'28, and Series B NCDs worth INR 5,813 crore at an 8.20% p.a. coupon. Both series mature on 27th Oct'31. The base issue of INR 7,000 crore was fully subscribed, with INR 816 crore retained via the greenshoe option.
Original exchange filing (PDF)
More announcements from Sun Pharmaceutical Industries Ltd
- Intimation of Schedule of Analyst/Institutional Investor Meeting 路 05 Nov 2026
- Q2FY27 Earnings Call Transcript 路 05 Nov 2026
- Clarification regarding news report relating to the Company''s Assam facility 路 03 Nov 2026
- The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on November 2, 2026, with reference to news appeared in https://www.thehindu.com/ dated October 30, 2026 quoting .... 路 02 Nov 2026
- Completion and results of postal ballot dated 01 October 2026 路 01 Nov 2026
- Q2FY27- Investor Call Audio Recording 路 31 Oct 2026
- Board Meeting Outcome - Conclusion 路 30 Oct 2026
- Unaudited Financial Results for the quarter and half year ended 30 September 2026 路 30 Oct 2026
